aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
iKang Guobin is a leading Chinese healthcare provider specializing in personalized, preventative medicine. The company offers a range of health management services, focusing on early detection and prevention of diseases. Their mission is to enhance the quality of life through comprehensive health assessments and tailored medical solutions. iKang serves a broad market, catering to individuals and corporate clients seeking proactive health management.
iKang has established itself as a prominent player in the healthcare industry, significantly impacting public health awareness and preventative care practices in China. The company's innovative approach and commitment to personalized healthcare have garnered recognition and trust among its clientele. Through its extensive network of medical facilities and expert professionals, iKang continues to advance the standard of preventative medicine in the region.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Healthcare, Preventative Medicine
Technology
HealthTech
Model Types
SaaS, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
China
When was iKang Guobin founded?
iKang Guobin was founded in 2003.
Where is iKang Guobin’s headquarters located?
iKang Guobin’s headquarters is located in Beijing, CN.
How many employees does iKang Guobin have?
iKang Guobin has 30 employees as of Feb 4, 2024.
How much has iKang Guobin raised to-date?
As of July 05, 2023, iKang Guobin has raised a total of $125M (USD) since Apr 10, 2014.
Add Comparison
Total Raised to Date
$125M
USD
Last Update Apr 10, 2014
Total Employees Over Time
30
As of Feb 2024
iKang Guobin Address
Beijing,
100022
People's Republic of China
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts